ISPE Drug Shortages Prevention Model
The ISPE Drug Shortages Prevention Model serves as a guide to help prevent drug shortages by providing quality, regulatory, and technical recommendations for the pharmaceutical manufacturing industry.
NORTH BETHESDA, Ma. (PRWEB)
May 23, 2023
ISPE, the International Society for Pharmaceutical Engineering has just released its new Drug Shortages Prevention Model.
The ISPE Drug Shortages Prevention Model serves as a guide to help prevent drug shortages by providing quality, regulatory, and technical recommendations for the pharmaceutical manufacturing industry. The ISPE Drug Shortages Team developed the model as a follow up to the ISPE Drug Shortages Prevention Plan that was released in 2014. The model provides expanded guidance that reflects the new insight and best practices that have emerged in the past several years.
“With the COVID-19 pandemic, various natural disasters and other unforeseen large-scale events, the importance of ensuring drug supply chain has never been more apparent,” says Tom Hartman, President and CEO of ISPE. “The Drug Shortages Prevention Model is a crucial step forward in ensuring that patients have access to the medicines they need. By providing guidance for manufacturers to prevent and mitigate potential shortages, the model will improve patient access to life sustaining medicines and the reliability of supply.”
The Drug Shortages Prevention Model describes three foundational areas for accountability: Quality and Manufacturing Maturity; Regulatory; and Technology & Innovation. The three areas cover twelve performance domains:
1. Pharmaceutical Quality System
2. Cultural Excellence
3. Workforce Capability
4. Supply and Distribution Resilience
5. Risk Management Planning
6. Data Analytics
7. Advanced Technology
8. Digital Solutions
9. Sustainability
10. Lifecycle Management
11. Regulatory Execution
12. Evolving Regulations
“If companies want to ensure they are prepared to avoid drug shortages whenever possible, they should strive to excel in each of the foundational performance domains outlined in the ISPE DSPM model,” says Diane Hustead, chair of the ISPE Drug Shortages Team. “Developing and implementing robust drug shortage prevention planning involves risk management at organizational, operational, and product-specific levels. It is truly an enterprise-wide endeavor.”
For more information contact:
Carol Winfield, Senior Director of Regulatory Operations, ISPE
Tel: +1-301-364-9210
Email: cwinfield@ispe.org
http://www.ISPE.org
About ISPE
“The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 20,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.
Share article on social media or email: